ACM
NVO

ADAR1 Capital Management’s Novo Nordisk NVO Stock Holding History

ADAR1 Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$2.38M – 280
2024
Q3 		$2.38M Buy
+20,000
New +$2.67M 0.39% 46

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

ADAR1 Capital Management's NVO Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Novo Nordisk (NVO) in Q1 2026: 33,000 shares worth $1.21M. The stake represents 0.07% of the portfolio and ranks #143 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in NVO as recently as Q2 2024.

ADAR1 Capital Management first reported a position in NVO in Q4 2023 and has held it in 4 quarters since. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • ADAR1 Capital Management held 33,000 shares of Novo Nordisk worth $1.21M as of Q1 2026.
  • Novo Nordisk was a new ADAR1 Capital Management position in Q1 2026.
  • Novo Nordisk made up 0.07% of ADAR1 Capital Management's portfolio in Q1 2026, its #143 holding.
  • ADAR1 Capital Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 4 quarters since.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.